Article: Minnelide reduces tumor burden in preclinical models of osteosarcoma
Cancer letters. 2013 July 28, v. 335, no. 2
2013
Abstract: Osteosarcoma is the most common bone cancer in children and adolescents with a 5-year survival rate of about 70%. In this study, we have evaluated the preclinical therapeutic efficacy of the novel synthetic drug, Minnelide, a prodrug of triptolide on ... ...
Abstract | Osteosarcoma is the most common bone cancer in children and adolescents with a 5-year survival rate of about 70%. In this study, we have evaluated the preclinical therapeutic efficacy of the novel synthetic drug, Minnelide, a prodrug of triptolide on osteosarcoma. Triptolide was effective in significantly inducing apoptosis in all osteosarcoma cell lines tested but had no significant effect on the human osteoblast cells. Notably, Minnelide treatment significantly reduced tumor burden and lung metastasis in the orthotopic and lung colonization models. Triptolide/Minnelide effectively downregulated the levels of pro-survival proteins such as heat shock proteins, cMYC, survivin and targets the NF-κB pathway. |
---|---|
Keywords | adolescents ; apoptosis ; children ; drugs ; heat shock proteins ; humans ; metastasis ; models ; osteosarcoma ; survival rate |
Language | English |
Dates of publication | 2013-0728 |
Size | p. 412-420. |
Publishing place | Elsevier Ireland Ltd |
Document type | Article |
ZDB-ID | 195674-7 |
ISSN | 1872-7980 ; 0304-3835 |
ISSN (online) | 1872-7980 |
ISSN | 0304-3835 |
DOI | 10.1016/j.canlet.2013.02.050 |
Database | NAL-Catalogue (AGRICOLA) |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1177: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.